Literature DB >> 25281494

Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.

Staci L Sudenga1, Sadeep Shrestha1, Maurizio Macaluso2, Edward E Partridge3, Gary L Johanning4, Chandrika J Piyathilake5.   

Abstract

OBJECTIVE: We evaluated time to clearance of high risk (HR) HPV infection in relation to functional variants in three genes (CYP1A1, GSTT1, and GSTM1).
METHODS: The study group consisted of 450 HR-HPV infected women from the Atypical squamous cells of undetermined significance-low-grade squamous intraepithelial Lesion Triage Study (ALTS) cohort followed up at the clinical center at Birmingham, Alabama. The Cox proportional hazard model with the Wei-Lin-Weisfeld (WLW) approach was used, controlling for relevant covariates.
RESULTS: Women who were polymorphic for CYP1A1 experienced an HR-HPV clearance rate that was 20% (HR=0.80, p=0.04) lower than women without the polymorphism for CYP1A1, adjusting for all other cofactors. The GSTM1 null genotype was associated with higher HR-HPV clearance rate (HR=1.39, p=0.006). The polymorphism in GSTT1 was not significantly associated with time to clearance of HR-HPV.
CONCLUSIONS: Xenobiotic metabolism genes may influence the natural history of HR-HPV infection and its progression to cervical cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALTS; CYP1A1; GSTM1; GSTT1; Host genetics

Mesh:

Substances:

Year:  2014        PMID: 25281494      PMCID: PMC4268049          DOI: 10.1016/j.ygyno.2014.09.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  20 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.

Authors:  S Hayashi; J Watanabe; K Nakachi; K Kawajiri
Journal:  J Biochem       Date:  1991-09       Impact factor: 3.387

3.  A need for true GSTM1 and GSTT1 genotyping.

Authors:  Fritz Parl
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-22       Impact factor: 4.254

4.  GSTM1 and GSTT1 copy number variation in population-based studies of endometrial cancer risk.

Authors:  Stalo Karageorgi; Jennifer Prescott; Jason Y Y Wong; I-Min Lee; Julie E Buring; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-10       Impact factor: 4.254

5.  Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.

Authors:  J W Kim; C G Lee; Y G Park; K S Kim; I K Kim; Y W Sohn; H K Min; J M Lee; S E Namkoong
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

6.  GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis.

Authors:  Konstantinos P Economopoulos; Souzana Choussein; Nikos F Vlahos; Theodoros N Sergentanis
Journal:  Int J Gynecol Cancer       Date:  2010-12       Impact factor: 3.437

7.  ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.

Authors:  M Schiffman; M E Adrianza
Journal:  Acta Cytol       Date:  2000 Sep-Oct       Impact factor: 2.319

8.  Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Authors:  S L Sudenga; S Shrestha
Journal:  Int J Infect Dis       Date:  2013-02-27       Impact factor: 3.623

9.  Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis.

Authors:  Lin-Bo Gao; Xin-Min Pan; Li-Juan Li; Wei-Bo Liang; Peng Bai; Li Rao; Xiao-Wei Su; Tao Wang; Bin Zhou; Yong-Gang Wei; Lin Zhang
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more
  4 in total

1.  GSTT1 and GSTM1 polymorphisms with human papillomavirus infection in women from southern Brazil: a case-control study.

Authors:  Ana Paula Reolon Bortolli; Valquíria Kulig Vieira; Indianara Carlotto Treco; Claudicéia Risso Pascotto; Guilherme Welter Wendt; Léia Carolina Lucio
Journal:  Mol Biol Rep       Date:  2022-05-04       Impact factor: 2.742

2.  Relationship between GSTM1 and GSTT1 polymorphisms and HPV infection: a systematic review.

Authors:  Ana Paula Reolon Bortolli; Valquíria Kulig Vieira; Emi Elaine Stefanski; Angela Khetly Lazarotto; Léia Carolina Lucio
Journal:  Mol Biol Rep       Date:  2021-08-13       Impact factor: 2.316

3.  Screening Cervical Cancer by the Pap Test – Relevance of Age Ranges Recommended by the Brazilian Programme for Prevention and Control

Authors:  Diogo Do Nascimento Franco; Adriana Cunha Vargas Tomáz; Angela Andréia Franca Gravena; Sandra Marisa Pelloso; Márcia Edilaine Lopes Consolaro
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

Review 4.  Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1zzm321990as an Important Associated Locus

Authors:  Debmalya Sengupta; Udayan Guha; Sagnik Mitra; Sampurna Ghosh; Samsiddhi Bhattacharjee; Mainak Sengupta
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.